• More than 13, 000 patients have been enrolled in one study to test the drug's safety and efficacy for an application with the Food and Drug Administration.

    FORBES: Magazine Article

  • Merck today withdrew its application with the Food and Drug Administration for Arcoxia, its next-generation painkiller.

    FORBES: Magazine Article

  • Pfizer then withdrew that use from its application after a Food and Drug Administration audit found dozens of discrepancies in its trial records.

    FORBES: Pfizer's Nigerian Plaintiffs Get Day In Court

  • Dendreon said today that it is planning to file an application with the Food and Drug Administration to have its cancer vaccine, Provenge, approved.

    FORBES: Magazine Article

  • Dendreon (nasdaq: DNDN - news - people ) said today that it is planning to file an application with the Food and Drug Administration to have its cancer vaccine, Provenge, approved.

    FORBES: A Cancer Vaccine's FDA Gambit

  • The updates are designed to address shortcomings and inconsistent application of the current rules through increased simplification and cutting administration costs.

    BBC: MEPs back new recycling targets for electronic waste

  • But the actual hosting of the application, the actual requirements for that application to exist in a cloud environment, to connect to the virtualized resources and whatever administration tools the cloud providers may give you to configure and maintain the application, will be, for the most part, controlled by the cloud provider.

    FORBES: Cloud Computing's Vendor Lock-In Problem: Why the Industry is Taking a Step Backward

  • The next day ImClone announced that the U.S. Food and Drug Administration had rejected its application for the approval of its Erbitux cancer drug, the one product in its pipeline, causing a steep decline in the share price.

    FORBES: Martha Trial: 'Everyone Is Telling The Same Story'

  • Genentech has finished filing its application with the U.S. Food and Drug Administration to sell Avastin as a treatment for colorectal cancer.

    FORBES: Magazine Article

  • Optimer, a San Diego-based company with no marketed products, completed a marketing application to the U.S. Food and Drug Administration on Nov. 30.

    FORBES: Optimer Gets NEJM Power

  • Last week, Merck withdrew an application with the U.S. Food and Drug Administration for a new drug that many hoped would revive its sagging arthritis franchise.

    FORBES: Magazine Article

  • Merck will submit an application to the U.S. Food and Drug Administration by the end of the year, and if all goes well, the drug could be approved six months later.

    FORBES: Key Merck Vaccine Prevents Cancer

  • This morning, Roche announced that the Food and Drug Administration refused to consider the application for the TDM-1 breast cancer drug based on technology that it licensed from Immunogen, a Waltham, Mass. biotechnology company.

    FORBES: Bad News For Immunogen

  • Those numbers mirror the results ImClone boasted of in 2001, before the U.S. Food and Drug Administration rejected a new drug application on the grounds that the data were not sufficient to prove that Erbitux worked.

    FORBES: Puncturing The ImClone Hype

  • Northfield is currently in the data analysis stage with PolyHeme and expects to report top-line trial data in the fourth quarter of this year, followed by filing its biologic license application with the U.S. Food and Drug Administration in the first half of 2007.

    FORBES: Magazine Article

  • In fact, a supergeneric will sometimes need a completely new drug application in order to gain approval from the Food and Drug Administration (FDA).

    FORBES: Magazine Article

  • Pfizer also said this morning that the Food and Drug Administration refused to accept a new drug application for an experimental medicine the company got from its acquisition of FoldRx.

    FORBES: Pfizer's Capsugel Sale Could Set Stage For Other Divestitures

  • The new application is similar to the previous one that the Food and Drug Administration refused to consider, insiders say--but with the crucial addition of positive new trial results from Germany's Merck KGaA .

    FORBES: Bristol, ImClone File On Erbitux

  • An application should be filed with the U.S. Food and Drug Administration by the first half of next year.

    FORBES: Lose Weight, Quit Smoking With One Pill

  • Mark Karvosky, a biotechnology analyst at Piper Jaffray, wrote in a note to investors that he expects the application to be filed with the U.S. Food and Drug Administration in June or July.

    FORBES: Two Wins For Biotech

  • "'We the People' is just part of the administration's commitment to open government and the code powering the application has been made available to anyone, including other countries, who wish to set up a similar system, " White House spokesman Matt Lehrich said.

    NPR: Chinese Air Their Cases By Petitioning White House

  • On the horizon, Novartis just submitted a new drug application for an arthritis drug, Prexige, to the U.S. Food and Drug Administration.

    FORBES: Novartis CEO Plays Waiting Game

  • Geron has submitted a 22, 000 page submission to the Food and Drug Administration - the body which approves clinical trials in the US - the largest application on record.

    BBC: White House stem cell shift expected

  • In December, the Food and Drug Administration rejected ImClone's (nasdaq: IMCL - news - people ) application to sell Erbitux.

    FORBES: Bristol Blinks, But ImClone's Eyes Are Glued Shut

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定